📄 Extracted Text (629 words)
FIRST AMENDMENT OF LETTER OF AGREEMENT REGARDING PURCHASE OF
PARTNERSHIP INTEREST
This FIRST AMENDMENT OF LETTER OF AGREEMENT REGARDING PURCHASE OF
PARTNERSHIP INTEREST effective September 3, 2013 by and between William H. Gates ("Gates") and Dr.
Boris Nikolic ("Dr. Nikolic") is made on and dated as of October 6.2015 ("Amendment").
WHEREAS, Gates and Dr. Nikolic entered into a certain Letter of Agreement Regarding Purchase of
Partnership Interests effective September 3, 2013 (the "Letter Agreement"); and
WHEREAS, while serving as an observer board member attending meetings the Board of Directors of
Foundation Medicine, Inc. ("FMI"), lock-ups and other restrictions on transfer with respect to the securities of
FMI which were imposed on members of FMI's Board of Directors have substantially limited Dr. Nikolic's
ability during the first two years of the Payment Period (as defined in the Letter Agreement) to exercise his rights
under the Letter Agreement to deliver to Gates Investment Entity Payment Demands (as defined in the Letter
Agreement) with respect to the securities of FMI; and
WHEREAS, Dr. Nikolic is no longer an observer member attending FMI's Board of Directors, and
Gates and Dr. Nikolic agree that in order to effectuate the original intention of the transactions contemplated
under the Letter Agreement, the opportunity to deliver Investment Entity Payment Demands freely and without
restriction, which was effectively lost while Dr. Nikolic served on FMI's Board of Directors during the first two
years of the Payment Period, should be restored by amending the Letter Agreement to extend the expiration date
of the Payment Period from September 3, 2016 until September 3, 2018; and
WHEREAS, pursuant to paragraph 2 of the section of the Letter Agreement encaptioned
"Miscellaneous", the Letter Agreement may not be amended other than in writing signed by Gates and Dr.
Nikolic;
NOW, THEREFORE, in consideration of the foregoing premises, and pursuant to paragraph 2 of the
section of the Letter Agreement encaptioned "Miscellaneous", Gates and Dr. Nikolic hereby agree as follows:
1. All capitalized terms used but not otherwise defined herein shall have the same meanings as are
ascribed to such terms in the Letter Agreement.
2. The first sentence of the section of the Letter Agreement encaptioned "Investment Entity
Payment Demands" is hereby deleted in its entirety and in place thereof is substituted the following:
"At any time and from time to time commencing on the date hereof and continuing through and including
September 3, 2018 (the "Payment Period"), Dr. Nikolic shall have the right, exercisable by written
notice to Gates, to demand payment of the increase in value in respect of all or a portion of the
Foundation Medicine Investment and/or in respect of up fifty percent (50%) or a portion of fifty percent
(50%) of the ResearchGate Investment (an "Investment Entity Payment Demand")."
3. Except as expressly provided in this Amendment, all the terms and provisions of the Letter
Agreement will continue in full force and effect.
4. This Amendment may be executed in counterparts, each of which shall be deemed an original,
but all of which when taken together shall constitute one and the same instrument. This Amendment may be
executed and delivered by delivery of a facsimile copy of an executed signature page or counterpart or by e-
mailing a PDF version of a signed signature page or counterpart, and each shall have the same force and effect as
the delivery of an originally executed signature page or counterpart.
5. This Amendment will be governed by and interpreted and construed under the laws of the State
of Washington without regard to its conflicts of law provisions.
E FTA_R1_02008496
EFTA02685163
2
Each of Gates and Dr. Nikolic have executed this Amendment with effect from the date appearing in the
first paragraph above.
WILLIAM H. GATES DR. BORIS NIKOLIC
2
EFTA_R1_02008497
EFTA02685164
ℹ️ Document Details
SHA-256
fcae8b85c83b67cd1b7e847065d6459a78a96ae008ddc65802d2824bdffde229
Bates Number
EFTA02685163
Dataset
DataSet-11
Document Type
document
Pages
2
Comments 0